007HO16067 ENCLAVE

Print/PDF
Registration Name WILRA SSI REGAL ENCLAVE-ET
Registration Number HO840003241466104
Primary NAAB Code 007HO16067
Secondary Code(s) 507HO16067
Status Inactive
Controller Name Select Sires (7)
Date of Birth 8/13/2021
aAa 432
DMS 234,123
GFI 12.7%
Genetic Codes * TC TL TD TP TR TV TY TM TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire T-SPRUCE RENEGADE REGAL-ET
MGS PINE-TREE CW LEGACY-ET
Beta Casein A2A2
Kappa Casein BB
Beta Lactoglobulin AB
INDEXES
NM$ 609, 89% R CM$ 653
NM Percentile 62% FM$ 510
GTPI 3246 GM$ 597
PRODUCTION TRAITS
1548 Dtrs 128 herds 96 % US 99% R
Milk 476 Fat, % 76 , +0.21%
SCS 2.68, 98% R Protein, % 41 , +0.09%
Feed Saved -284 , 56% R Milking Speed 7.22 , 96% R
Health & Fertility
Productive Life 3.2      90% R Mastitis 3.6      85% R
Heifer Livability -0.2       70% R Metritis 0.5      88% R
Livability -       77% R D. Abom 0.4      90% R
DPR 1.2      90% R Ketosis 1.0      83% R
FSC 5.5      89% R R. Placenta 0.1      88% R
HCR 1.8      95% R Milk Fever 0.0      74% R
CCR 2.3      90% R
SCR -        -
DIA 2.2      58% R
RSP 1.1      83% R
Calving Traits
Sire CE 0.9      98% R 4216 Obs
Daughter CE 1.2      89% R 442 Obs, 500 Dtrs
Sire SB 3.9      96% R 4171 Obs
Daughter SB 4.1      90% R 405 Obs, Dtrs
Gestation Length -2.3      98% R 51 Obs, 516 Dtrs
Early First Calving 4.2      85% R 20 Obs, 57 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
177 Dtrs 44 herds 96% R
PTA Type 0.75 UDC 1.48
HCC 1.19 BWC 0.66
FLC -0.18
Linear Traits
Stature 0.00
Strength 0.35
Weak
Body Depth -0.44
Shallow
Dairy Form -0.87
Closed
Rump Angle 1.14
Sloped
Thurl Width 0.20
Sloped
Rear Legs-Side View 0.20
Wide
Rear Legs-Rear View 0.61
Straight
Foot Angle 0.27
Steep
Feet & Legs Score -0.35
Low
F.U. Attachment -1.62
Straight
Rear Udder Height 1.39
High
Rear Udder Width 0.83
Wide
Udder Cleft 0.06
Strong
Udder Depth 0.61
Straight
Front Teat Placement 0.89
Close
Rear Teat Placement 0.45
Close
Teat Length 0.00
-2
0
2

CDCB August 2026; Base of Evaluation: HO